Moderna, Inc. - Common Stock (OQ:MRNA)

Competitors with Recent Insider Filings
No competitors with recent insider filings.
Latest 10 SEC filings (by transaction date) for MRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 6th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 3/19 Nov 29/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $20.54
Nov 25/19 Nov 22/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $20.48
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -200,000  
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Common Stock S - Open market or private sale -200,000 $20.18
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 200,000 $0.040
Nov 19/19 Nov 15/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -336 $19.38
Nov 19/19 Nov 15/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -10,710 $19.02
Nov 12/19 Nov 8/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $17.38
Nov 5/19 Nov 1/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -4,500 $16.68
Nov 5/19 Nov 1/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -6,546 $15.66
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 6th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 3/19 Nov 29/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $20.54
Nov 25/19 Nov 22/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $20.48
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -200,000  
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Common Stock S - Open market or private sale -200,000 $20.18
Nov 22/19 Nov 20/19 Hutt Peter Barton Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 200,000 $0.040
Nov 19/19 Nov 15/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -336 $19.38
Nov 19/19 Nov 15/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -10,710 $19.02
Nov 12/19 Nov 8/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -11,046 $17.38
Nov 5/19 Nov 1/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -4,500 $16.68
Nov 5/19 Nov 1/19 Bancel Stephane Indirect Ownership Common Stock S - Open market or private sale -6,546 $15.66
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $MRNA

StockTwits